Exhibition Announcement: Japan Healthcare Venture Summit (Oct 9-11)
Epistra will exhibit at the “Japan Healthcare Venture Summit (JHVS)” at Pacifico Yokohama.
At Booth V-22 within JHVS, we will showcase AI-powered cell culture condition optimization technology using Epistra Accelerate, along with our efforts toward improving bioprocess efficiency. In addition, CEO Yosuke Ozawa will deliver a pitch at the JHVS SHOWCASE, presenting Epistra’s vision and technological innovations.
We look forward to meeting you at the venue.
Event Details
- Dates: October 9 (Wed) - 11 (Fri), 2024
- Venue: Pacifico Yokohama (1-1-1 Minato Mirai, Nishi-ku, Yokohama, Kanagawa)
- Organizer: Ministry of Health, Labour and Welfare (Pharmaceutical Industry & Venture Support Policy Office)
- Exhibition Location: V-22, Japan Healthcare Venture Summit 2024
- JHVS SHOWCASE Pitch: October 11 (Fri) 10:10-10:12 (Pitch 8)
- Speaker: CEO Yosuke Ozawa
Visitor registration (free) is available here.
Related Articles
Epistra Contributes Article on "AI-Robot-Driven Drug Development" to Pharmacia, Journal of the Pharmaceutical Society of Japan
Epistra CTO Taku Tsuzuki and CEO Yosuke Ozawa contributed an article on AI-robot-driven drug development to Pharmacia, Vol. 62 No. 7, published by the Pharmaceutical Society of Japan.
Cell Culture Optimization Software 'CellTune Ver.2' Launches Globally
Epistra Inc. announces the global launch of 'CellTune Ver.2,' the updated version of the co-developed cell culture optimization software with Shimadzu Corporation, on June 29, 2026. The new version introduces cloud-based subscription delivery and overseas expansion of custom media manufacturing services.
Speaking Engagement: CEO Yosuke Ozawa Presented at the 10th Shonan iPark Regenerative Medicine Seminar
On June 3, 2026, Epistra Inc. CEO Yosuke Ozawa presented at the 10th Shonan iPark Regenerative Medicine Seminar, sharing implementation case studies and future prospects for AI and mathematical optimization in regenerative medicine process development.